Fundraising Fox
SeQure Dx
Waltham, US · Founded 2020 · 4 known investors
Find your way into SeQure Dx
Sign up to see every warm intro you have to SeQure Dx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the SeQure Dx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
EE
Ellen E. SheetsChief Executive Officer, Co-founder2020–2023Ellen E. Sheets has held leadership roles including Chief Medical Officer and Chief Executive Officer across medical devices, life sciences, and healthcare organizations. She is Chief Executive Officer of SeQure Dx.
Board
NH
Investors · 4
Bold Capital Partnerslisted by Bold Capital PartnersSanta Monica
How we know: Bold Capital Partners's portfolio page · Not right? Tell us
Digitalis Ventureslisted by Digitalis VenturesNew York · $100K – $10M
How we know: Digitalis Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
RiverVest Venture Partnerslisted by RiverVest Venture PartnersSt. Louis · $500K – $3M
How we know: RiverVest Venture Partners's portfolio page · Not right? Tell us
KdT VenturesreportedAustin · $500K – $3M
How we know: the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$22.3M disclosed across 3 rounds · 2021–2023
▶$2.2MraisedDec 2023 · 7 investors · BiotechnologyRule 506(b)
▶$2.2MraisedDec 2023 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Carl M. BerkeDirector
- Isaac ZikeDirector
- Sanjay PothenExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $2.2M
- Minimum investment
- $1
- First sale
- Nov 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$2.6MraisedDec 2023 · 7 investors · BiotechnologyRule 506(b)
▶$2.6MraisedDec 2023 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ellen SheetsExecutive Officer, Director
- Nancy HongDirector
- Carl M. BerkeDirector
- Offering amount
- $8M
- Amount sold
- $2.6M
- Minimum investment
- $1
- Proceeds to insiders
- $1M
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$17.5MraisedApr 2021 · 9 investors · BiotechnologyRule 506(b)
▶$17.5MraisedApr 2021 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Carl M. BerkeDirector
- Nancy HongDirector
- Ellen E. SheetsExecutive Officer, Director
- Offering amount
- $17.5M
- Amount sold
- $17.5M
- Minimum investment
- $1M
- Proceeds to insiders
- $1M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are SeQure Dx's investors?
- SeQure Dx's investors include Bold Capital Partners, Digitalis Ventures, RiverVest Venture Partners, KdT Ventures.
- How much funding has SeQure Dx raised?
- SeQure Dx has disclosed $22.3M raised across 3 rounds.
- Where is SeQure Dx headquartered?
- SeQure Dx is headquartered in Waltham, US.